Impact of multi-agent systemic therapy on all-cause and disease-specific survival for people living with HIV who are diagnosed with non-Hodgkin lymphoma: population-based analyses from the state of Georgia-Reference-Cited by-同舟云学术

Impact of multi-agent systemic therapy on all-cause and disease-specific survival for people living with HIV who are diagnosed with non-Hodgkin lymphoma: population-based analyses from the state of Georgia

Published:2022-10-28 Issue:1 Volume:64 Page:151-160
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lipscomb Joseph¹²,Switchenko Jeffrey M.²³,Flowers Christopher R.⁴,Gillespie Theresa W.²⁵⁶,Wortley Pascale M.⁷,Bayakly A. Rana⁷,Almon Lyn⁸,Ward Kevin C.⁸⁹

Affiliation:

1. Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA

2. Winship Cancer Institute, Emory University, Atlanta, GA, USA

3. Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA

4. Division of Cancer Medicine, Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX, USA

5. Department of Surgical Oncology, Emory University School of Medicine, Atlanta, GA, USA

6. Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA

7. Georgia Department of Public Health, Atlanta, GA

8. Georgia Center for Cancer Statistics, Rollins School of Public Health, Emory University, Atlanta, GA, USA

9. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA

Funder

NIH

Winship Cancer Institute of Emory University

National Cancer Institute

Centers for Disease Control and Prevention

Biostatistics and Bioinformatics Shared Resource of the Winship Cancer Institute

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2133539

Reference28 articles.

1. Survival Deficit for HIV-Infected Lymphoma Patients in the National Cancer Database

2. Are Cancer Outcomes Worse in the Presence of HIV Infection?

3. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era

4. Clinical Presentation, Treatment, and Outcomes Among 65 Patients with HIV-Associated Lymphoma Treated at the University of North Carolina, 2000–2010

5. Opportunistic Infection and Immunologic Function in Patients With Human Immunodeficiency Virus-Associated Non-Hodgkin's Lymphoma Treated With Chemotherapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management;Blood Reviews;2024-03